MDR Makes EU ‘Much Less Attractive’ For Start-Ups, Says Medtronic EMEA Chief
Executive Summary
The fragility of start-ups belies their value in medtech innovation, and they do not need unnecessary regulatory complications.
You may also be interested in...
Medtronic Looks Beyond The World Of Doctors And Devices In New Approach To Markets
Health warning to global medtechs: The world’s largest medical device company is taking steps to strengthen key account management, retain its market share hold and set up new health care partnerships.
DTx And Drug Deal Sees Closed Loop Medicine And Teva Team Up On Precision Care
Medicines are still typically prescribed based on average effects in a population and rarely dose-optimized for the individual, says Closed Loop Medicine. The company sees a new strategic partnership with Teva UK as another step in advancing personalized medicine.
Swiss-EU Standoff Set To End? Medtechs Eye MRA Action
Negotiations aimed at renewing the close trading relationship and barrier-free mutual market access between Switzerland and the EU got underway on 19 March. Swiss medtech companies welcomed the move, stressing the need for the defunct mutual recognition agreement to be updated.